Bausch + Lomb (NYSE:BLCO) announced today that Joseph C. Papa will step down as the company’s board chair and CEO. The optical and ophthalmic device maker has appointed Thomas W. Ross, Sr., to serve as its chair and has begun the search for a new CEO. Papa will remain as CEO and a member of […]
Personnel Moves
iRhythm brings another Dexcom veteran into its C-suite
iRhythm Technologies (Nasdaq:IRTC) announced today that it appointed Chad Patterson as its next chief commercial officer. Patterson will join the wearable electrocardiogram monitors developer’s executive leadership team and, as CCO, he will oversee the company’s commercial strategy, operations and execution. He most recently served as chief marketing officer at Dexcom. He will make the move […]
MiMedx appoints Kate Surdez as new chief human resources officer
MiMedx today announced it appointed Kate Surdez as chief human resources officer, effective immediately. The newly created MiMedx chief human resources officer role will guide processes and programs that support sustainable growth. Surdez has more than 20 years of experience in human resources and has led talent acquisition, total rewards, succession and workforce planning, performance […]
J&J EVP, general counsel Michael Ullmann set to retire
Johnson & Johnson (NYSE:JNJ) announced today that, after 33 years, Michael Ullmann will retire as EVP and general counsel. Ullmann’s retirement will be made effective on Oct. 17, 2022, at which point Elizabeth Forminard will succeed him as EVP and general counsel, as well as take up a position as a member of Johnson & […]
Ra Medical appoints interim CFO
Ra Medical Systems (NYSE:RMED) announced today that it appointed Brian D. Conn as its interim chief financial officer (CFO). Conn will serve as the company’s principal financial officer and principal accounting officer, effective immediately. He has served as a consultant to the Carlsbad, California-based developer of the Dabra excimer laser system for treating vascular diseases […]
Sherlock Biosciences appoints new chief commercial officer
Sherlock Biosciences announced today that it appointed Julie Garlikov as its first chief commercial officer. In her role, Garlikov will serve as a member of the point-of-need molecular diagnostic developer’s executive team and will be responsible for driving commercial strategy for the decentralized diagnostics platform. Garlikov will report to Bryan Dechairo, who serves as president […]
Owens & Minor elects Carissa Rollins to board of directors
Owens & Minor (NYSE:OMI) announced today that it has elected Illumina executive Carissa Rollins to its board of directors. Rollins, who serves as chief information officer (CIO) at clinical genomics company Illumina, joins the board at Richmond, Virginia-based Owens & Minor effective today, July 12. She directs the global information systems for the leader in […]
Biolase appoints chief financial, operating officers
Biolase (Nasdaq:BIOL) announced today that it appointed Jennifer Bright as its new CFO and Steven Sandor as its new COO. Lake Forest, California-based Biolase — a developer of laser technologies for the dental space — made the promotions of both executives effective immediately. Both will report to Biolase President and CEO John Beaver. Bright has […]
Lyra Therapeutics appoints new chief medical officer
Lyra Therapeutics (Nasdaq:LYRA) announced today that it appointed Dr. Richard Nieman as its new chief medical officer (CMO). Nieman’s appointment as CMO of Lyra, which develops the XTreo — a platform for enabling precise, sustained and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues — will be made […]
Teva appoints former Vertex exec as new head of R&D, CMO
Teva Pharmaceuticals (NYSE:TEVA) announced today that it appointed Dr. Eric A. Hughes as VP of global R&D and chief medical officer. Hughes’ employment becomes effective Aug. 1, 2022, and he will be based out of Tel Aviv, Israel-based Teva’s U.S. headquarters in Parsippany, New Jersey. Get the full story at our sister site, Drug Delivery Business […]
Titan Medical names Cary G. Vance as new president, CEO
Titan Medical (Nasdaq:TMDI) announced that it appointed Cary G. Vance as its new president and CEO. Vance will succeed Titan chair of the board of directors, Paul Cataford, who had served as interim president and CEO since December 2021, when David McNally, who previously held the corner office, resigned. Vance’s appointment was made effective today. […]
